washington alex azar former pharmaceutical company executive u.s. president donald trump top pick run department health human service two source knowledge confidential process say condition anonymity wednesday azar serve eli lilly decade include five years president u.s. lilly usa llc unit white house decline comment tom price resign hhs secretary september seven months post face sharp criticism use taxpayer-funded private travel stint eli lilly azar serve general counsel deputy secretary hhs president george w. bush new hhs secretary task implement trump administration efforts unwind obamacare top campaign promise oversee drug industry trump say get away murder charge high price prescription medications azar serve board directors biotechnology innovation organization drug industry lobby several years nomination would raise question administration seriousness low drug price name float replace price include seema verma administrator center medicare medicaid service scott gottlieb food drug administration commissioner republicans control chamber congress white house repeatedly fail repeal replace obama affordable care act prompt trump take step dismantle program trump administration follow threat cut billions dollars subsidy payments insurers shorten obamacare open enrollment period slash advertise program 90 percent cut fund group help people sign health insurance october trump also sign executive order would weaken obamacare make easy americans buy bare-bones health insurance plan administration already plan change 2019. last month propose rule give state flexibility benefit must cover insurance obamacare insurers cover set 10 benefit maternity newborn care prescription drug ex-pharma exec azar top choice run u.s. health agency source